Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-30 5:39 pm Purchase | 2024-12-22 | 13G | Vivos Therapeutics, Inc. VVOS | Mitchell P. Kopin | 297,315 4.990% | 297,315 (New Position) | Filing History |
| 2024-12-20 3:17 pm Purchase | 2024-12-17 | 13G | Vivos Therapeutics, Inc. VVOS | V-CO Investors LLC | 514,498 9.900% | 514,498 (New Position) | Filing History |
| 2024-11-14 4:49 pm Purchase | 2024-09-30 | 13G | Vivos Therapeutics, Inc. VVOS | ARMISTICE CAPITAL LLC | 250,277 4.990% | 75,178 (+42.93%) | Filing History |
| 2024-11-14 4:05 pm Sale | 2024-09-30 | 13G | Vivos Therapeutics, Inc. VVOS | Ionic Ventures, LLC | 83,000 1.800% | -329,064 (-79.86%) | Filing History |
| 2024-09-24 2:59 pm Purchase | 2024-09-19 | 13G | Vivos Therapeutics, Inc. VVOS | Ionic Ventures, LLC | 412,064 8.700% | 412,064 (New Position) | Filing History |
| 2024-02-14 5:42 pm Purchase | 2023-12-31 | 13G | Vivos Therapeutics, Inc. VVOS | Huntsman Ronald Kirk | 94,794 4.300% | 94,794 (New Position) | Filing History |
| 2024-02-14 3:57 pm Purchase | 2023-12-31 | 13G | Vivos Therapeutics, Inc. VVOS | ARMISTICE CAPITAL LLC | 175,099 9.990% | 175,099 (New Position) | Filing History |
| 2023-02-10 4:05 pm Purchase | 2022-12-31 | 13G | Vivos Therapeutics, Inc. VVOS | Huntsman Ronald Kirk | 90,033 9.000% | 1,480 (+1.67%) | Filing History |
| 2022-02-14 5:03 pm Purchase | 2021-12-31 | 13G | Vivos Therapeutics, Inc. VVOS | Huntsman Ronald Kirk | 88,553 9.620% | 5,200 (+6.24%) | Filing History |
| 2022-02-14 5:02 pm Purchase | 2021-12-31 | 13G | Vivos Therapeutics, Inc. VVOS | Singh Gurdev Dave | 129,988 14.100% | 1,200 (+0.93%) | Filing History |
| 2021-02-16 2:34 pm Purchase | 2020-12-31 | 13G | Vivos Therapeutics, Inc. VVOS | Singh Gurdev Dave | 128,788 17.700% | 128,788 (New Position) | Filing History |
| 2021-02-16 2:32 pm Purchase | 2020-12-31 | 13G | Vivos Therapeutics, Inc. VVOS | Huntsman Ronald Kirk | 83,353 11.500% | 83,353 (New Position) | Filing History |